On Thursday last week Jericho attended the Central Drug Authority (CDA) workshop to provide input to the drafting of the 2018-2022 National Drug Master Plan (NDMP). The NDMP is implemented for a period of 5 years, the current NDMP was implemented in 2013 running from 2013-2018.
The NDMP is formulated by CDA in terms of the Prevention and Treatment for Substance Abuse Act 2008. The CDA is a statutory body, reporting to parliament, that is mandated to coordinate all efforts and initiatives to combat substance abuse. The NDMP seeks to assist implementers in the field of substance abuse to prevent and treat substance abuse holistically. South Africa is required to combat the substance abuse problem in line with United Nations Conventions.
Key factors influencing the choice of strategy for the Draft NDMP 2018-2022:
1. Recognition of addiction as a brain disease rather than a social illness (and recognition that addiction is a relapsing chronic disease); and
2. Realisation that the total elimination of drug use and abuse is not possible and reaffirmation of UNGASS’s vision to ‘achieve a society free of drug abuse rather than a drug free society.’
The proposed new NDMP consists of 6 chapters, key drafting points from each chapter were:
There’s a need for research and data collection.
The 4 operational interventions required to achieve the vision are:
1. Demand reduction (prevention initiatives);
2. Continuum of treatment (which includes reintegration into society),
3. Safety (control of accessibility), and
4. Supply reduction and related matters (i.e. drug related crime, money laundering, people trafficking and judicial interventions).
Need to monitor and evaluate outcomes to see if strategy is working.
Need to adapt strategy based on monitoring and evaluation.
Covers status of substance use in South Africa.
This includes substance use patterns, access to and demand for substances and socio demographic characteristics of individuals.
Covers the implications and consequences of ‘Substance Used Disorder’ (SUD) which was previously called Substance Abuse. In this drafting section, it was stated that ‘SUD is a brain disease as well as a relapsing chronic disease and it is an illness with multiple underlying problems.’ So, it’s no longer a social illness, it’s now proposed to be defined as a medical illness as it’s said to be a brain disease and it’s chronic.
A Community-based approach is required.
The extent of SUD highlighted – ITO World Drug Report 2016: 1 in 20 adults between 15 and 64 years used at least 1 drug. 12 million are people who inject drugs of whom 14% are living with HIV.
Specific departments were identified as pivotal in overcoming South Africa's addiction problems, however specific roles were not assigned to each department. These are to be drawn up by each department themselves in operational plans called Mini Drug Master Plans (MDMP’s).
Selection of the NDMP strategy.
Covers the strategic planning cycle and provides factors that reduce use and dependency such as: Stability and opportunity,
Appropriate rehab services,
Psychological relocation and
Strategic implications of the draft 2018-2022 NDMP.
Defines impact, overall outcome, output, objective, activity and assumptions and how to apply them in the real situation.
For e.g. roles of Provincial Substance Abuse Forums (PSAF’s): set up executive committee and assign portfolio to members as follows: Prevention & Treatment; Demand Reduction; Control; Supply Reduction; Research & Development; Communication & Marketing; and Monitoring & Evaluation.
Roles of civil society organisations.
Roles of the Local Drug Action Committees (LDAC’s). Members of the LDAC’s need to compile an action plan to implement the Provincial Drug Master Plan; implement its action plans; provide reports to the PSAF's i.t.o. actions, progress, challenges and other related matters.
Monitoring, evaluation and reporting. To be ongoing and systematic.
To assess relevance, performance, value for money, impact and sustainability.
All departments are to report to the CDA on their MDMP’s quarterly and annually using agreed templates and KPI’s.
The implementation evaluation of the NDMP will be conducted midway, i.e. after 2.5 years to assess if it’s on track. Another evaluation to be done on completion.
If you have any questions or comments on the draft 2018-2022 NDMP please call the CDA Secretariat: Dr E Mabuza-Mokoko on (012) 312-7558